[Daily Mail, where America gets its news] - The FDA told drugmakers on Wednesday to pull all Zantac and ranitidine - its generic version - from store shelves and online retailers in the US
- Evidence of a cancer-linked chemical called NDMA was first found in batches of the drugs in September 2019
- NDMA is considered a 'probable' cause of colorectal, kidney and stomach cancers based on animal studies
- FDA officials initially said the risk was relatively low and said patients should keep taking the popular heartburn drugs
- Now they've reversed that decision and said the levels of the chemical are 'unacceptable'
- Anyone with Zantac or ranitidine should throw away the tablets, FDA says
What odds a key ingredient was made in China? |